Prospective comparative analysis of the angiogenic capacity of monocytes and CD1331 cells in a murine model of hind limb ischemia

Cytotherapy

Volumn 11, Issue 8, 2009, Pages 1041-1051

  López Holgado, Natalia ^a,b   Alberca, Mercedes ^a,b   Sánchez Guijo, Fermin Martin ^a,b   Villarón, Eva Maria ^a,b   Rivas, Jose Vicente ^c   López Novoa, Jose Miguel ^c   Briñón, Jesus Garcia ^c   Arévalo, Miguel Angel ^c   Oterino, Enrique ^a   Santamaría, Carlos ^a,b   San Miguell, Jesus Fernando ^a,b   Del Cañizo, Maria Consuelo ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b ISCIII)   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Blood fl ow; Capillary count; Hind limb ischemia; Monocytes

Indexed keywords

CD133 ANTIGEN; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; LIMB PERFUSION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 71149121866     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653240903191719     Document Type: Article

References (53)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der ZR, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275(5302):964-967
2. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95(3):952-958
3. Doyle B. Endothelial Progenitor Cells. Endothelium 2006;13:403-410
4. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing defi nitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005 Sep 1; 106(5):1525-1531
5. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109(5):1801-1809
6. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker P, Verfaillie C. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002;109:337-346
7. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004;104(9):2752-2760
8. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 2000; 65(5):287-300.
9. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 2001;49(3):671-680
10. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 2003;107(8):1164-1169
11. Romagnani P, Annunziato F, Liotta F, Lazzeri E, Mazzinghi B, Frosali F et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005;97:314-322
12. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, et al. Human CD34+AC133-VEGFR-2- cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Experimental Hematology 2007; 35:1109-1118
13. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, et al. Failure of blood-island formation and vasculogenesis in Flk-1 defi cient mice. Nature 1995;376:62-66
14. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998;125(4):725-732
15. Wang L. Endothelial and hematopoietic cell fate of human embryonic stem cells. Trend Cardiovasc Med 2006; 16(3):89-94.
16. Shi Q, Rafi i S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circuolating bone marrow-derived endothelial cells. Blood 1998;92(2):362-367
17. Bailey AS, Jiang S, Afentoulis M, Baumann CI, Schroeder DA, Olson SB, et al. Transplanted adulThematopoietic stem cells differentiate into functional endothelial cells. Blood 2004; 103(1):13-19
18. Cogle CR, Scott EW. The hemangioblast: cradle to clinic. Exp Hematol 2004;32(10):885-890
19. Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000;95(10):3106-3112
20. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001;115(1):186-194 (Pubitemid 32995115)
21. de Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, et al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998;16(6):387-396
22. Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, Sumitran-Holgersson S. Only a specific subject of human peripheral blood monocytes has endothelial-like functional capacity. Blood 2005;106:2347-2355
23. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Cir Res 1999 Aug 6; 85(3):221-228
24. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM, et al. Determination of bone marrow-derived endothelial progenitor cell signifi cance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002;30(8):967-972
25. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003; 107(3):461-468.
26. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001 Feb 6;103(5):634-637
27. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 2002;106(15):2019-2025
28. Fuchs S, Baffour R, Zhou YF, Shou M, Pierre A, Tio FO, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37(6):1726-1732
29. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Amano K, Iba O, et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioescler Thromb Vasc Biol 2002 Nov 1;22(11):1804-1810
30. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003;348 (7):593-600.
31. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology and possible clinical relevance. J Cell Mol Med 2004;8:498-508.
32. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95(4): 343-353 (Pubitemid 39100452)
33. Rafi i S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003;9:702-712
34. Murasawa S, Asahara T. Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda) 2005;20:36-42.
35. Blann AD. Assessment of endothelial dysfunction: focus on atherothrombotic disease. Pathophysiol Haemost Thromb 2003;33:256-261
36. Lopez-Holgado N, Alberca M, Sanchez-Guijo F, Villaron E, Almeida J, Martin A, et al. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy 2007;9(1):14-22.
37. Glod J, Kobiler D, Noel M, Koneru R, Lehrer S, Medina D, et al. Monocytes form a vascular barrier and participate in vessel repair after brain injury. Blood 2006 Feb 1;107(3): 940-946
38. Del Canizo MC, Fernandez ME, Lopez A, Vidriales B, Villaron E, Arroyo JL, et al. Immunophenotypic analysis of mielodysplastic syndromes. Hematologica 2003;88:402-407
39. Eguchi M, Masuda H, Asahara T. Endotelial progenitor cells for postnatal vasculogenesis. Clin Exp Nephrol 2007;11: 18-25.
40. Cogle CR, Madlambayan GJ, Hubsher G, Beckman C, Speisman R, Tran-Son-Tay R. Marrow cell therapies for cardiovascular diseases. Experimental Hematology 2008; 36:687-694
41. Aranguren XL, McCue JD, Hendrickx B, Zhu XH, Du F, Chen E, et al. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. J Clin Invest 2008; 118:505-514
42. Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC. CD34- blood derived human endothelial cell progenitors. Stem Cells 2001;19(4):304-312
43. Theil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002;283(6):2411-2419
44. Fujiyama S, Amano K, Uehira, Yoshida M, Nishiwaki Y, Nozawa Y, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein- 1-dependent manner and accelerate reendothelization as endothelial progenitor cells. Circ Res 2003;93(10):980-989
45. Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 2006;108(7):2438-2445
46. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008;214:3-9.
47. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7(4):430-436
48. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 2002 Jul-Dec;3(3-4):221-225 (Pubitemid 37329397)
49. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000;86(12):1198-1202
50. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004;94(2):230-238
51. Maddedu P, Emanueli C, Pelosi E, Salis MB, Cerio AM, Bonanno G, et al. Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J 2004;18(14):1737-1739
52. Therold J, Pipp F, Fernandez B, Xing Z, Heil M, Tillmanns H, et al.Transplantation of monocytes: a novel strategy for in vivo augmentation of collateral vessel growth. Human Gene Therapy 2004;15:1-12.
53. Silvestre JS, Golosa A, Brun V, Potteaux S, Esposito B, Duriez M, et al. Transplantation of bone-marrow derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation 2003;108:2839-2842